Navigation Links
Former Sanofi-aventis and US Oncology Executive Joins New Century Health as Chief Executive Officer
Date:1/16/2012

BREA, Calif., Jan. 16, 2012 /PRNewswire/ -- New Century Health announced today that its board of directors has appointed Atul Dhir, M.D., Ph.D., chief executive officer.  Dr. Dhir will spearhead the national expansion of New Century Health's specialty care management services focused on oncology and cardiology.  Water Street Healthcare Partners, a strategic private equity firm focused exclusively on health care that invested in New Century Health last year, recruited Dr. Dhir to the position.

(Logo: http://photos.prnewswire.com/prnh/20120116/CG35564LOGO)

Dr. Dhir joins New Century Health from his position as CEO of BiPar Sciences, Inc., a Sanofi-aventis biotech subsidiary that develops new cancer drugs.  He previously served as a senior executive with US Oncology, the largest provider of cancer care in the United States.  During his 10 years with the company, Dr. Dhir led several businesses, including the company's Cancer Research Group, one of the nation's leading cancer drug development companies.  Dr. Dhir has also held senior positions in the health care division of Monsanto Company and at McKinsey & Company.

"Dr. Dhir possesses a rare combination of deep scientific expertise and years of operational experience. He has an impressive 20-year history of leading and growing highly specialized health care businesses focused on transforming care," said Steve Cosler, chairman of New Century Health and an operating partner with Water Street.  "Dr. Dhir clearly stood out as the leader best suited to building on New Century's strong foundation to expand its services to payers and providers across the country."

Dr. Dhir has advised numerous health care organizations and currently serves on the advisory boards of several health care companies.  He completed his doctorate of philosophy in molecular biology from the University of Oxford, where he studied as a Rhodes Scholar.  He received his medical degree from the All India Institute of Medical Sciences in New Delhi, India. 

"My career has been dedicated to leading innovative organizations that are committed to improving health care on a large scale.  New Century Health has a unique and collaborative approach to improving the quality of patient care, while reducing the administrative work and overall costs of medical care in cancer, cardiology and other specialties.  I am excited to lead and grow the company to deliver these urgently needed services to patients, payers and providers across the country," said Dr. Dhir.

Dr. Dhir assumes the CEO position immediately.

 

About New Century Health

New Century Health is a national specialty care management company that provides innovative technology and clinical solutions to enhance the quality of patient care, while reducing the administrative work and improving the cost efficiency associated with the delivery of care.  Its customers include both payers and doctors providing specialty care services to members of Medicare, Medicaid and commercial payers. New Century Health is a company of Water Street, a strategic private equity firm focused exclusively on health care. New Century Health is an official licensee of the NCCN Drugs & Biologics Compendium™. To learn more about New Century Health, visit www.NewCenturyHealth.com.

 

 


'/>"/>
SOURCE New Century Health
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Former Speaker of the House Newt Gingrich Featured Wednesday
2. Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Therapeutics Europe
3. Former Cables to Go/Lastar Inc. Employee's Move to Form American Consumer Cables Pays Off
4. Dynamic Signs Asset Acquisition Deal With Cannex and Brings Onboard Leading Medical Cannabis Research Scientist Dr. Robert Melamede, Former Chairman of the Biology Department, University of Colorado
5. Former Telomolecular CEO Clarifies SEC Settlement
6. Shire Successfully Settles Former TKT Shareholder Appraisal Rights Litigation
7. Former NASDAQ International President Among Execs Launching Firm to Access Global Markets
8. Kendle Reappoints Former CFO Timothy M. Mooney to Board of Directors
9. Cynvec LLC(SM) Appoints Former Johnson & Johnson Executive Frank D. Stonebanks as President and Chief Executive Officer
10. Cyntellect Appoints Former BD Biosciences Executive Andre Lubarsky as Director of Sales - North America
11. Cyntellect Appoints Former Millipore and BD Biosciences Executives to Head Up its Product Marketing Efforts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... Tenn. , Feb. 24, 2017 ... ("Provectus" or the "Company"), a clinical-stage oncology and ... regarding the deadline to participate in its previously ... units, consisting of shares of common stock and ... and holders of listed warrants. ...
(Date:2/24/2017)... China Cord Blood Corporation (NYSE: CO ) ... blood collection, laboratory testing, hematopoietic stem cell processing and ... results for the third quarter and first nine months ... Third Quarter of Fiscal 2017 Highlights ... increased by 18.6% to RMB200.9 million ($28.9 million). ...
(Date:2/24/2017)...  OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a company ... Opinion Leader event to highlight new clinical data that ... at the upcoming 2017 ASCO-SITC Immuno-Oncology Symposium and the ... held in-person and via live webcast on Tuesday, February ... at the Lotte New York Palace Hotel in ...
(Date:2/23/2017)... , Feb. 23, 2017 /PRNewswire/ - The Fight ... for Cancer Research (OICR) are pleased to report that ... A financing, with Johnson & Johnson Innovation – JJDC, ... include venture groups HealthCap, TPG Biotechnology Partners, and Genesys ... ...
Breaking Biology Technology:
(Date:2/9/2017)... Feb. 9, 2017 The biomass boiler market ... the biomass boiler market globally in terms of revenue ... boilers. The market for biomass boilers has been segmented ... application, and country/region. The market based on feedstock type, ... residues, biogas & energy crops, urban residues, and others. ...
(Date:2/8/2017)... Feb. 7, 2017 The biometrics market ... the confluence of organizations, desires to better authenticate ... systems (password and challenge questions), biometrics is quickly ... systems. The market is driven by use cases, ... consumer and enterprise uses cases, with consumer-facing use ...
(Date:2/7/2017)... New York , February 7, 2017 ... as ID Global Solutions Corporation [OTC: IDGS], ("Ipsidy" or ... management and electronic transaction processing services, is pleased to ... of the Company. Effective January 31, 2017, ... the Board of Directors, CEO and President.  An experienced ...
Breaking Biology News(10 mins):